Qfitlia (fitusiran) — United Healthcare
Hemophilia A
Initial criteria
- Diagnosis of hemophilia A AND prescribed for the prevention of bleeding episodes (routine prophylaxis)
- Diagnosis of hemophilia B AND prescribed for the prevention of bleeding episodes (routine prophylaxis)
Reauthorization criteria
- Documentation of positive clinical response to Qfitlia therapy
Approval duration
12 months